Expression levels of hENT2, DCK, and CDA did not affect response including (OR, CR, CCR, mCR or HI) rate in MDS patients treated with decitabine (Fig. 1a–c; Additional file 1a, b). The gene discussed is DCK; the disease is myelodysplastic syndrome.